XBiotech Insider Trades
NASDAQ: XBITHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
XBiotech insider activity
No XBiotech insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows MCKENZIE W THORPE (Director) reporting a transaction in 250,000 shares at $10.00 on Dec 16, 2021. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put XBIT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
XBIT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Dec 16, 2021 | MCKENZIE W THORPEDirector | Tax withholding | 213,493 | $2.50M | Form 4 |
| Dec 16, 2021 | MCKENZIE W THORPEDirector | Option exercise | 250,000 | $2.50M | Form 4 |
| Oct 18, 2021 | SIMARD JOHNChief Executive Officer | Sale | 33,000 | $431.25K | Form 4 |
| Oct 15, 2021 | SIMARD JOHNChief Executive Officer | Sale | 17,000 | $226.47K | Form 4 |
| Oct 14, 2021 | SIMARD JOHNChief Executive Officer | Sale | 21,125 | $272.52K | Form 4 |
| Oct 13, 2021 | SIMARD JOHNChief Executive Officer | Sale | 10,875 | $139.53K | Form 4 |
| Oct 12, 2021 | SIMARD JOHNChief Executive Officer | Sale | 18,000 | $229.94K | Form 4 |
| Oct 7, 2021 | SIMARD JOHNChief Executive Officer | Sale | 39,286 | $489.11K | Form 4 |
| Oct 6, 2021 | SIMARD JOHNChief Executive Officer | Sale | 10,714 | $134.26K | Form 4 |
| Oct 5, 2021 | SIMARD JOHNChief Executive Officer | Sale | 14,218 | $180.06K | Form 4 |
| Oct 4, 2021 | SIMARD JOHNChief Executive Officer | Sale | 23,681 | $309.86K | Form 4 |
| Oct 1, 2021 | SIMARD JOHNChief Executive Officer | Sale | 19,684 | $260.49K | Form 4 |
| Sep 30, 2021 | SIMARD JOHNChief Executive Officer | Sale | 18,558 | $242.46K | Form 4 |
| Sep 29, 2021 | SIMARD JOHNChief Executive Officer | Sale | 16,396 | $219.80K | Form 4 |
| Sep 28, 2021 | SIMARD JOHNChief Executive Officer | Sale | 6,263 | $89.36K | Form 4 |
| Sep 27, 2021 | SIMARD JOHNChief Executive Officer | Sale | 29,890 | $442.79K | Form 4 |
| Sep 24, 2021 | SIMARD JOHNChief Executive Officer | Sale | 11,418 | $165.41K | Form 4 |
| Sep 23, 2021 | SIMARD JOHNChief Executive Officer | Sale | 9,892 | $145.22K | Form 4 |
| Sep 22, 2021 | SIMARD JOHNChief Executive Officer | Sale | 19,669 | $297.76K | Form 4 |
| Sep 21, 2021 | SIMARD JOHNChief Executive Officer | Sale | 16,860 | $256.91K | Form 4 |
| Sep 20, 2021 | SIMARD JOHNChief Executive Officer | Sale | 13,471 | $202.91K | Form 4 |
| Jul 14, 2021 | SIMARD JOHNChief Executive Officer | Sale | 50,000 | $907.35K | Form 4 |
| Jul 9, 2021 | MacAdam Donald H.Director | Option exercise | 10,000 | $44.00K | Form 4 |
| Jul 9, 2021 | Libby PeterDirector | Option exercise | 25,000 | $194.00K | Form 4 |
| Mar 22, 2021 | SIMARD JOHNChief Executive Officer | Option exercise | 500,000 | $3.75M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4